Guidelines for diagnosis and management of Paget's disease of bone in Japan
โ Scribed by Shinjiro Takata; Jun Hashimoto; Kiyoshi Nakatsuka; Noriko Yoshimura; Kousei Yoh; Ikko Ohno; Hiroo Yabe; Satoshi Abe; Masao Fukunaga; Masaki Terada; Masaaki Zamma; Stuart H. Ralston; Hirotoshi Morii; Hideki Yoshikawa
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 579 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0914-8779
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
To assess the use of quantitative bone scanning (QBS) in the monitoring of patients with intravenous pamidronate-treated symptomatic monostotic Paget's disease of bone in whom biochemical markers of bone turnover are relatively normal. Methods. QBS was performed in 9 patients and the results were e
In 1978, The Paget Foundation was founded as an organization devoted to providing information concerning Paget's disease of bone to patients and medical professionals. Over the years, the Foundation expanded its programs to include other disorders of abnormal bone resorption, including primary hyper
Orthopedic complications of Paget's disease wcur commonly and arise as a result of chronically accelerated bone remodeling in focal regions of the skeleton. Complications include pathologic fractures with delayed union, progressive skeletal deformity, chronic bone pain and pagetic arthritis. The new
The goals of treatment of Paget's disease must be readdressed in the context of the availability of potent bsphosphonate compounds, including pamidronate and, more recently, alendronate and risedronate. These agents differ from the traditional mainstays of therapy, salmon calcitonin and etidmnate, i